CATX
Price:
$2.95
Market Cap:
$227.89M
Perspective Therapeutics, Inc., including its various operations, specializes in the comprehensive lifecycle – from development and manufacturing to sales and marketing – of radiopharmaceutical products and medical devices. These advanced solutions are designed to treat cancer and other serious malignant conditions, serving markets both within the United States and globally. A flagship product offered by the company is its CS-1 Cesium-131 brachytherapy seeds. This treatment is specifically utilized for a broad range of cancers, such as those impacting the prostate, brain, lung, head and neck regions, gynecological system, pelvic/abdominal areas, and colorectal tissues. The company distribute...[Read more]
Industry
Medical - Devices
IPO Date
2005-11-10
Stock Exchange
AMEX
Ticker
CATX
According to Perspective Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.09. This represents a change of 25.21% compared to the average of -1.67 of the last 4 quarters.
The mean historical PE Ratio of Perspective Therapeutics, Inc. over the last ten years is -44.42. The current -2.09 PE Ratio has changed 370.50% with respect to the historical average. Over the past ten years (40 quarters), CATX's PE Ratio was at its highest in in the March 2026 quarter at -0.04. The PE Ratio was at its lowest in in the March 2023 quarter at -236.05.
Average
-44.42
Median
-30.38
Minimum
-137.44
Maximum
-1.97
Discovering the peaks and valleys of Perspective Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 102.87%
Maximum Annual PE Ratio = -1.97
Minimum Annual Increase = -82.74%
Minimum Annual PE Ratio = -137.44
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -1.97 | -24.07% |
| 2024 | -2.59 | -45.38% |
| 2023 | -4.75 | -48.66% |
| 2022 | -9.24 | -61.02% |
| 2022 | -23.72 | -82.74% |
| 2021 | -137.44 | 19.53% |
| 2020 | -114.98 | 102.87% |
| 2019 | -56.67 | 52.98% |
| 2018 | -37.05 | -33.61% |
| 2017 | -55.80 | -45.08% |
The current PE Ratio of Perspective Therapeutics, Inc. (CATX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.10
5-year avg
-8.45
10-year avg
-44.42
Perspective Therapeutics, Inc.’s PE Ratio is greater than Profound Medical Corp. (-5.47), greater than TriSalus Life Sciences, Inc. (-2.89), less than Nyxoah S.A. (-0.65), less than Solana Company (-0.05), greater than Invivyd, Inc. (-2.59), greater than MaxCyte, Inc. (-3.23), less than Nano-X Imaging Ltd. (-1.45), greater than Anteris Technologies Global Corp. (-2.44), less than Electromed, Inc. (31.70), greater than Neuronetics, Inc. (-2.28),
| Company | PE Ratio | Market cap |
|---|---|---|
| -5.47 | $207.88M | |
| -2.89 | $154.67M | |
| -0.65 | $63.37M | |
| -0.05 | $94.59M | |
| -2.59 | $128.73M | |
| -3.23 | $129.62M | |
| -1.45 | $116.22M | |
| -2.44 | $359.79M | |
| 31.70 | $320.27M | |
| -2.28 | $85.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Perspective Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Perspective Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Perspective Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Perspective Therapeutics, Inc. (CATX)?
What is the highest PE Ratio for Perspective Therapeutics, Inc. (CATX)?
What is the 3-year average PE Ratio for Perspective Therapeutics, Inc. (CATX)?
What is the 5-year average PE Ratio for Perspective Therapeutics, Inc. (CATX)?
How does the current PE Ratio for Perspective Therapeutics, Inc. (CATX) compare to its historical average?